Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.

Jan 9 (Reuters) - Shares of Allscripts-Misys Healthcare Solutions Inc were up more than 7 percent, a day after the healthcare software firm posted its first quarterly results post merger. Allscripts ...

Health IT providers Allscripts-Misys Healthcare Solutions and Eclipsys plan to merge in an all-stock deal worth US$1.3 billion [b], with the companies focused on creating a universally accepted ...

) is set to close its merger with Eclipsys next week, and Auriga raised its Price Target on the stock to $21 from $20. Auriga maintains a Buy rating on the stock. In a client note, Auriga notes that ...

The complex field of health-care information may soon be a little more streamlined. On Tuesday, Chicago-based electronic medical records provider Allscripts announced it has agreed to merge with ...

Shares of electronic health records company Allscripts-Misys Healthcare Solutions Inc. rose to their highest price in nearly two years Wednesday after the health records company reported quarterly ...

Allscripts-Misys MDRX reports Q2 EPS $0.18 vs consensus of $0.17. Allscripts-Misys reports Q2 revenue $190.9 million vs consensus of $185.29 million. Revenues rose 13.9% year over year. The company ...

Doctors with an iPhone or iPod Touch will be able to view patients’ electronic health records using a new application available on Apple’s Apps Store. Allscripts-Misys Healthcare Solutions created the ...